BIOCELLVIA IS A PIONEER IN COMPOUND VALIDATION ASSAY DEVELOPMENT
Reliable assessment of candidate molecules is a key issue for the healthcare industry, as it’s crucial for proper decision-making throughout research process.
To address these preclinical research needs, Biocellvia has developed numerical imaging analysis, providing researchers with tailor-made assays.
« Our technology is the guarantee of the same accuracy and reliability all along your research proceedings. »
Yvon JULE, co-founder and CSO
BIOCELLVIAAn innovative company to support preclinical research READ MORE
TECHNOLOGYA tailor-made process for digital tissue imaging analysis READ MORE
PATHOLOGIESCompound validation assays to support many pathologies READ MORE
R & DContinuously improving technology to better support scientists READ MORE
PUBLICATIONMany publications & studies to support Biocellvia’s technology READ MORE
1 unique technology
dedicated to preclinical research
Used in more than